These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33292260)

  • 1. PPARα and PPARβ/δ are negatively correlated with proinflammatory markers in leukocytes of an obese pediatric population.
    Vargas-Sánchez K; Vargas L; Urrutia Y; Beltrán I; Rossi AB; Lozano HY; Guarín J; Losada-Barragán M
    J Inflamm (Lond); 2020 Oct; 17(1):35. PubMed ID: 33292260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor.
    Yang Y; Tong Y; Gong M; Lu Y; Wang C; Zhou M; Yang Q; Mao T; Tong N
    Cell Signal; 2014 Feb; 26(2):268-78. PubMed ID: 24269940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
    Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
    Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells.
    Dressel U; Allen TL; Pippal JB; Rohde PR; Lau P; Muscat GE
    Mol Endocrinol; 2003 Dec; 17(12):2477-93. PubMed ID: 14525954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of the dual peroxisome proliferator activated receptor (PPAR)α/γ agonist aleglitazar in attenuating TNF-α-mediated inflammation and insulin resistance in human adipocytes.
    Massaro M; Scoditti E; Pellegrino M; Carluccio MA; Calabriso N; Wabitsch M; Storelli C; Wright M; De Caterina R
    Pharmacol Res; 2016 May; 107():125-136. PubMed ID: 26976796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of peroxisome proliferator-activated receptors (PPAR) α and -γ of rat brain astrocytes in the course of activation by toll-like receptor agonists.
    Chistyakov DV; Aleshin SE; Astakhova AA; Sergeeva MG; Reiser G
    J Neurochem; 2015 Jul; 134(1):113-24. PubMed ID: 25818681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis.
    Francque S; Verrijken A; Caron S; Prawitt J; Paumelle R; Derudas B; Lefebvre P; Taskinen MR; Van Hul W; Mertens I; Hubens G; Van Marck E; Michielsen P; Van Gaal L; Staels B
    J Hepatol; 2015 Jul; 63(1):164-73. PubMed ID: 25703085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human epicardial adipose tissue expresses glucose-dependent insulinotropic polypeptide, glucagon, and glucagon-like peptide-1 receptors as potential targets of pleiotropic therapies.
    Malavazos AE; Iacobellis G; Dozio E; Basilico S; Di Vincenzo A; Dubini C; Menicanti L; Vianello E; Meregalli C; Ruocco C; Ragni M; Secchi F; Spagnolo P; Castelvecchio S; Morricone L; Buscemi S; Giordano A; Goldberger JJ; Carruba M; Cinti S; Corsi Romanelli MM; Nisoli E
    Eur J Prev Cardiol; 2023 Jun; 30(8):680-693. PubMed ID: 36799940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor (PPAR)β/δ, a possible nexus of PPARα- and PPARγ-dependent molecular pathways in neurodegenerative diseases: Review and novel hypotheses.
    Aleshin S; Strokin M; Sergeeva M; Reiser G
    Neurochem Int; 2013 Oct; 63(4):322-30. PubMed ID: 23811400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptors and the control of inflammation.
    Cabrero A; Laguna JC; Vázquez M
    Curr Drug Targets Inflamm Allergy; 2002 Sep; 1(3):243-8. PubMed ID: 14561188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-α inhibits PPARβ/δ activity and SIRT1 expression through NF-κB in human adipocytes.
    Serrano-Marco L; Chacón MR; Maymó-Masip E; Barroso E; Salvadó L; Wabitsch M; Garrido-Sánchez L; Tinahones FJ; Palomer X; Vendrell J; Vázquez-Carrera M
    Biochim Biophys Acta; 2012 Sep; 1821(9):1177-85. PubMed ID: 22683888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like peptide 1 receptor (GLP-1R) agonist relieved asthmatic airway inflammation via suppression of NLRP3 inflammasome activation in obese asthma mice model.
    Hur J; Kang JY; Kim YK; Lee SY; Lee HY
    Pulm Pharmacol Ther; 2021 Apr; 67():102003. PubMed ID: 33588055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of the interleukin-1 receptor-associated kinase (IRAK)-1 is associated with adipose tissue inflammatory state in obesity.
    Ahmad R; Shihab PK; Thomas R; Alghanim M; Hasan A; Sindhu S; Behbehani K
    Diabetol Metab Syndr; 2015; 7():71. PubMed ID: 26312071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels.
    Yessoufou A; Wahli W
    Swiss Med Wkly; 2010; 140():w13071. PubMed ID: 20842602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity-related vascular dysfunction persists after weight loss and is associated with decreased vascular glucagon-like peptide receptor in female rats.
    Kiernan R; Persand D; Maddie N; Cai W; Carrillo-Sepulveda MA
    Am J Physiol Heart Circ Physiol; 2022 Aug; 323(2):H301-H311. PubMed ID: 35749717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipose tissue distribution and quantification of PPARbeta/delta and PPARgamma1-3 mRNAs: discordant gene expression in subcutaneous, retroperitoneal and visceral adipose tissue of morbidly obese patients.
    Bortolotto JW; Margis R; Ferreira AC; Padoin AV; Mottin CC; Guaragna RM
    Obes Surg; 2007 Jul; 17(7):934-40. PubMed ID: 17894154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).
    Tjokroprawiro A
    Acta Med Indones; 2006; 38(3):160-6. PubMed ID: 17119268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycine regulates inflammatory markers modifying the energetic balance through PPAR and UCP-2.
    Almanza-Perez JC; Alarcon-Aguilar FJ; Blancas-Flores G; Campos-Sepulveda AE; Roman-Ramos R; Garcia-Macedo R; Cruz M
    Biomed Pharmacother; 2010 Oct; 64(8):534-40. PubMed ID: 19864106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor beta/delta as a therapeutic target for metabolic diseases.
    Bedu E; Wahli W; Desvergne B
    Expert Opin Ther Targets; 2005 Aug; 9(4):861-73. PubMed ID: 16083348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DHEA Administration Activates Transcription of Muscular Lipid Metabolic Enzymes via PPARα and PPARδ in Obese Rats.
    Horii N; Sato K; Mesaki N; Iemitsu M
    Horm Metab Res; 2016 Mar; 48(3):207-12. PubMed ID: 26406917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.